🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

5 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
6 {Calories}
Total Carbohydrates
1.5 Gram(s) (1% DV)
30 mg (150% DV)
✅ 2.1× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 30mg UL 35mg
GO(TM) MATRIX (Proprietary blend)
3635 mg

Other Ingredients

Maltodextrin Natural & Artificial flavors Silica Citric Acid Sucralose Acesulfame-K FD&C Red No. 40

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Important Note(s): Do not exceed one (1) serving (1 scoop) per training day. Avoid eating food or drinking a protein shake within an hour after consuming GO(TM). To avoid sleeplessness, do not take within four (4) hours of bedtime. Taking GO(TM) with food, or on a full stomach, may diminish its effects.

Suggested Use: Use on training days only. Take one (1) serving (1 scoop) approximately 15-30 minutes prior to training, blended into 6-8 ounces of cold water or beverage, or as suggested by a qualified healthcare practitioner.

⚠️ Warnings & Precautions

Please read entire label before use.

Warnings: Not intended for use by persons under age 18.

Do not exceed recommended dose. Do not take for more than eight (8) consecutive weeks.

This product should not be taken by pregnant or lactating women. Get the consent of a licensed physician before using this product, especially if you are taking medication, have a medical condition, or thinking about becoming pregnant.

Too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally rapid heartbeat. Discontinue use if you experience dizziness, severe headache, rapid heartbeat or shortness of breath.

Caffeine Warning: The recommended serving of this product contains approximately as much caffeine as three cups of coffee.

KEEP THIS PRODUCT AND ALL SUPPLEMENTS OUT OF THE REACH OF CHILDREN.

Do not consume caffeine, or combine with synephrine, including but not limited to coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

Additional Information

CarnoSyn(R) Carnosine Synthesizer

{Signature} Jay Cutler "THIS IS WHAT I TAKE" STACK

Many individuals notice the initial energy, mental focus, and volumizing effects within just 5-15 minutes of ingestion, with a progressive increase every few minutes thereafter. Others may begin to notice initial signs within 30-45 minutes of ingestion.

Rev. 01-001-TWT001 10/12

FREE INSIDE JAY'S T-SHIRT SHAKER CUP 4X MR. OLYMPIA POSTER

PRE-WORKOUT PERFORMANCE PRE-TRAINING POWDER

When combined with a proper exercise and nutrition regimen. Statements based on early-stage independent 3rd party in vivo and / or in vitro model scientific research data findings.

Jay Cutler 4X Mr. Olympia APPROVED 2006 / 2007 / 2009 / 2010

bpi EXT i

SUPPLEMENT WITH JAY'S STACK FOR A BETTER AND MORE DEFINING PHYSIQUE.

30 SERVINGS

Product Details

UPC / SKU 8 51780 00497 5
DSLD Entry Date 2014-03-25
Product Type Other Combinations
Form Powder
Brand BPI
Bundle This Is What I Take Stack
DSLD ID 31220
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →